Clinical trial
Procedural Advantages of a Novel Drug-Eluting Coronary Stent With Ultra-Thin Struts and Bioabsorbable Abluminal Polymer Coating in an All-Comers Registry
NCT02881216 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Procedural Advantages of a Novel Drug-Eluting Coronary Stent With Ultra-Thin Struts and Bioabsorbable Abluminal Polymer Coating in an All-Comers Registry
- Lead sponsor
- University Hospital Heidelberg
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- June 30, 2016
- Enrollment
- 814 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.